关于罕见 CNVs 和多基因风险对精神特征的综合影响的合作研究

IF 6.1 2区 医学 Q1 CLINICAL NEUROLOGY European Neuropsychopharmacology Pub Date : 2024-10-01 DOI:10.1016/j.euroneuro.2024.08.072
Molly Sacks , Marieke Klein , Omar Shanta , Mohammad Ahangari , Oanh Hong , Jeff MacDonald , Bhooma Thiruvahindrapuram , Sebastien Jacquemont , Tim Bigdeli , Matthew Oetjens , Mart Kals , Stephen H. Scherer , Jonathan Sebat , The Bipolar Disorder, Schizophrenia, Post-Traumatic Stress Disorder, Attention-Deficit/Hyperactivity Disorder, Major Depressive Disorder, Autism Spectrum Disorder and Copy Number Variation working groups of the Psychiatric Genomics Consortium , Genes to Mental Health Network
{"title":"关于罕见 CNVs 和多基因风险对精神特征的综合影响的合作研究","authors":"Molly Sacks ,&nbsp;Marieke Klein ,&nbsp;Omar Shanta ,&nbsp;Mohammad Ahangari ,&nbsp;Oanh Hong ,&nbsp;Jeff MacDonald ,&nbsp;Bhooma Thiruvahindrapuram ,&nbsp;Sebastien Jacquemont ,&nbsp;Tim Bigdeli ,&nbsp;Matthew Oetjens ,&nbsp;Mart Kals ,&nbsp;Stephen H. Scherer ,&nbsp;Jonathan Sebat ,&nbsp;The Bipolar Disorder, Schizophrenia, Post-Traumatic Stress Disorder, Attention-Deficit/Hyperactivity Disorder, Major Depressive Disorder, Autism Spectrum Disorder and Copy Number Variation working groups of the Psychiatric Genomics Consortium ,&nbsp;Genes to Mental Health Network","doi":"10.1016/j.euroneuro.2024.08.072","DOIUrl":null,"url":null,"abstract":"<div><div>Recurrent CNVs are known to be major risk factors in neuropsychiatric disorders, yet phenotypic variability between carriers of the same CNV remains unexplained. A possible explanation is that the effect of a CNV depends on genetic background, which can be quantified by a polygenic risk score (PRS). Using data from the PGC and UKBB (combined n=543,111), this project aims to characterize the individual and combined effects of recurrent CNVs and PRS on six major psychiatric disorders: ADHD, ASD, BD, PTSD, MDD, and SCZ.</div><div>We first quantified the effects of 42 recurrent CNV loci across all 6 disorders using logistic regression. After Bonferroni correction, 24 loci had a significant association with at least one disorder in either the deletion or duplication. We next documented evidence for the traditional liability threshold model of disease risk; cases carrying CNVs with weak main effects had higher PRS than cases carrying CNVs with strong main effects. This pattern was strongest for SCZ (p=2.13e-4) but was evident in BD as well. Additionally, we tested a composite CNV-PRS model, which demonstrates how PRS can be a useful tool for predicting outcomes in CNV carriers. For example, a carrier of 16p11.2 proximal duplication (a well-known SCZ association) is not at increased risk for SCZ if they have a low PRS-SCZ.</div><div>To increase power to detect statistical interactions between CNVs and PRS, we conducted a meta-analysis of CNVxPRS effects on BMI and height in four biobanks: UK Biobank, Estonian Biobank, Geisinger Health, and Million Veterans Program, (n=975,408). Of the 32 CNVs that were sufficiently powered for this analysis (n &gt; 225), 3 had nominally significant (p &lt; .05) interactions with PRS on BMI. In all three cases, the sign on the interaction was the same as the main effect of the CNV, suggesting that these interactions are synergistic. When we collapsed CNVs by their main effect direction, we saw a significant negative interaction between the BMI decreasing CNVs and PRS (p=9.98e-4). These interactions were robust to rescaling of the BMI response variable via inverse normalization or Box-Cox. We observed no significant interactions for Height.</div><div>Taken together, these analyses demonstrate that the effect of recurrent CNVs is moderated by PRS. In addition to emphasizing the importance of considering genetic background when studying the effects of rare variants, this study also demonstrates that genetic factors may have non-additive effects on complex traits.</div></div>","PeriodicalId":12049,"journal":{"name":"European Neuropsychopharmacology","volume":"87 ","pages":"Pages 28-29"},"PeriodicalIF":6.1000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"COLLABORATIVE STUDY OF THE COMBINED EFFECTS OF RARE CNVS AND POLYGENIC RISK ON PSYCHIATRIC TRAITS\",\"authors\":\"Molly Sacks ,&nbsp;Marieke Klein ,&nbsp;Omar Shanta ,&nbsp;Mohammad Ahangari ,&nbsp;Oanh Hong ,&nbsp;Jeff MacDonald ,&nbsp;Bhooma Thiruvahindrapuram ,&nbsp;Sebastien Jacquemont ,&nbsp;Tim Bigdeli ,&nbsp;Matthew Oetjens ,&nbsp;Mart Kals ,&nbsp;Stephen H. Scherer ,&nbsp;Jonathan Sebat ,&nbsp;The Bipolar Disorder, Schizophrenia, Post-Traumatic Stress Disorder, Attention-Deficit/Hyperactivity Disorder, Major Depressive Disorder, Autism Spectrum Disorder and Copy Number Variation working groups of the Psychiatric Genomics Consortium ,&nbsp;Genes to Mental Health Network\",\"doi\":\"10.1016/j.euroneuro.2024.08.072\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Recurrent CNVs are known to be major risk factors in neuropsychiatric disorders, yet phenotypic variability between carriers of the same CNV remains unexplained. A possible explanation is that the effect of a CNV depends on genetic background, which can be quantified by a polygenic risk score (PRS). Using data from the PGC and UKBB (combined n=543,111), this project aims to characterize the individual and combined effects of recurrent CNVs and PRS on six major psychiatric disorders: ADHD, ASD, BD, PTSD, MDD, and SCZ.</div><div>We first quantified the effects of 42 recurrent CNV loci across all 6 disorders using logistic regression. After Bonferroni correction, 24 loci had a significant association with at least one disorder in either the deletion or duplication. We next documented evidence for the traditional liability threshold model of disease risk; cases carrying CNVs with weak main effects had higher PRS than cases carrying CNVs with strong main effects. This pattern was strongest for SCZ (p=2.13e-4) but was evident in BD as well. Additionally, we tested a composite CNV-PRS model, which demonstrates how PRS can be a useful tool for predicting outcomes in CNV carriers. For example, a carrier of 16p11.2 proximal duplication (a well-known SCZ association) is not at increased risk for SCZ if they have a low PRS-SCZ.</div><div>To increase power to detect statistical interactions between CNVs and PRS, we conducted a meta-analysis of CNVxPRS effects on BMI and height in four biobanks: UK Biobank, Estonian Biobank, Geisinger Health, and Million Veterans Program, (n=975,408). Of the 32 CNVs that were sufficiently powered for this analysis (n &gt; 225), 3 had nominally significant (p &lt; .05) interactions with PRS on BMI. In all three cases, the sign on the interaction was the same as the main effect of the CNV, suggesting that these interactions are synergistic. When we collapsed CNVs by their main effect direction, we saw a significant negative interaction between the BMI decreasing CNVs and PRS (p=9.98e-4). These interactions were robust to rescaling of the BMI response variable via inverse normalization or Box-Cox. We observed no significant interactions for Height.</div><div>Taken together, these analyses demonstrate that the effect of recurrent CNVs is moderated by PRS. In addition to emphasizing the importance of considering genetic background when studying the effects of rare variants, this study also demonstrates that genetic factors may have non-additive effects on complex traits.</div></div>\",\"PeriodicalId\":12049,\"journal\":{\"name\":\"European Neuropsychopharmacology\",\"volume\":\"87 \",\"pages\":\"Pages 28-29\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Neuropsychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0924977X24002712\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Neuropsychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0924977X24002712","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

众所周知,复发性 CNV 是神经精神疾病的主要风险因素,但同一 CNV 携带者之间的表型差异仍无法解释。一种可能的解释是,CNV 的影响取决于遗传背景,而遗传背景可以通过多基因风险评分(PRS)来量化。本项目利用 PGC 和 UKBB(合计 n=543,111)的数据,旨在描述复发性 CNV 和 PRS 对六种主要精神疾病的个体和综合影响:我们首先使用逻辑回归量化了 42 个复发性 CNV 位点对所有 6 种疾病的影响。经过Bonferroni校正后,24个基因位点在缺失或重复中至少与一种疾病有显著关联。接下来,我们记录了疾病风险传统责任阈值模型的证据;携带弱主效应 CNV 的病例比携带强主效应 CNV 的病例具有更高的 PRS。这种模式在 SCZ 中最为明显(p=2.13e-4),但在 BD 中也很明显。此外,我们还测试了 CNV-PRS 复合模型,该模型展示了 PRS 如何成为预测 CNV 携带者结局的有用工具。例如,16p11.2近端重复(众所周知与SCZ有关)的携带者如果PRS-SCZ较低,则患SCZ的风险不会增加。为了提高检测CNV与PRS之间统计学相互作用的能力,我们对四个生物库中CNVxPRS对BMI和身高的影响进行了荟萃分析:英国生物库、爱沙尼亚生物库、Geisinger Health 和百万退伍军人计划(n=975,408)。在本分析充分支持的 32 个 CNV(n >225)中,有 3 个与 PRS 对 BMI 的交互作用具有名义上的显著性(p <.05)。在所有三个案例中,交互作用的符号与 CNV 的主效应相同,表明这些交互作用具有协同作用。当我们将 CNV 按其主效应方向折叠时,我们发现 BMI 下降的 CNV 与 PRS 之间存在显著的负交互作用(p=9.98e-4)。这些交互作用对通过反向归一化或盒-柯克斯(Box-Cox)对 BMI 响应变量进行重新缩放是稳健的。总之,这些分析表明,复发性 CNV 的影响受到 PRS 的调节。除了强调在研究罕见变异的影响时考虑遗传背景的重要性外,这项研究还证明了遗传因素可能对复杂性状产生非加性影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COLLABORATIVE STUDY OF THE COMBINED EFFECTS OF RARE CNVS AND POLYGENIC RISK ON PSYCHIATRIC TRAITS
Recurrent CNVs are known to be major risk factors in neuropsychiatric disorders, yet phenotypic variability between carriers of the same CNV remains unexplained. A possible explanation is that the effect of a CNV depends on genetic background, which can be quantified by a polygenic risk score (PRS). Using data from the PGC and UKBB (combined n=543,111), this project aims to characterize the individual and combined effects of recurrent CNVs and PRS on six major psychiatric disorders: ADHD, ASD, BD, PTSD, MDD, and SCZ.
We first quantified the effects of 42 recurrent CNV loci across all 6 disorders using logistic regression. After Bonferroni correction, 24 loci had a significant association with at least one disorder in either the deletion or duplication. We next documented evidence for the traditional liability threshold model of disease risk; cases carrying CNVs with weak main effects had higher PRS than cases carrying CNVs with strong main effects. This pattern was strongest for SCZ (p=2.13e-4) but was evident in BD as well. Additionally, we tested a composite CNV-PRS model, which demonstrates how PRS can be a useful tool for predicting outcomes in CNV carriers. For example, a carrier of 16p11.2 proximal duplication (a well-known SCZ association) is not at increased risk for SCZ if they have a low PRS-SCZ.
To increase power to detect statistical interactions between CNVs and PRS, we conducted a meta-analysis of CNVxPRS effects on BMI and height in four biobanks: UK Biobank, Estonian Biobank, Geisinger Health, and Million Veterans Program, (n=975,408). Of the 32 CNVs that were sufficiently powered for this analysis (n > 225), 3 had nominally significant (p < .05) interactions with PRS on BMI. In all three cases, the sign on the interaction was the same as the main effect of the CNV, suggesting that these interactions are synergistic. When we collapsed CNVs by their main effect direction, we saw a significant negative interaction between the BMI decreasing CNVs and PRS (p=9.98e-4). These interactions were robust to rescaling of the BMI response variable via inverse normalization or Box-Cox. We observed no significant interactions for Height.
Taken together, these analyses demonstrate that the effect of recurrent CNVs is moderated by PRS. In addition to emphasizing the importance of considering genetic background when studying the effects of rare variants, this study also demonstrates that genetic factors may have non-additive effects on complex traits.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Neuropsychopharmacology
European Neuropsychopharmacology 医学-精神病学
CiteScore
10.30
自引率
5.40%
发文量
730
审稿时长
41 days
期刊介绍: European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.
期刊最新文献
Whole-brain functional neuroimaging correlates of cognitive flexibility impairments in people with mental disorders: A transdiagnostic coordinate-based meta-analysis Prescription sequences in bipolar disorder – A nationwide Danish register-based study of 19,927 individuals followed for 10 years Artificial intelligence in healthcare: Revolution or unfulfilled promise? Methylation profile scores of environmental exposures and risk of relapse after a first episode of schizophrenia Letter to the editor concerning: “Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1